Baicalein ameliorates ischemic brain damage through suppressing proinflammatory microglia polarization via inhibiting the TLR4/NF-κB and STAT1 pathway

[Display omitted] •Baicalein improves infarct volume and sensorimotor functions after MCAO.•Baicalein modulates microglial polarization to anti-inflammatory phenotype.•Baicalein regulates the neuroinflammatory response.•Baicalein affects polarization via inhibiting the TLR4/NF-κB and STAT1 activity....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain research 2021-11, Vol.1770, p.147626-147626, Article 147626
Hauptverfasser: Ran, Yuanyuan, Qie, Shuyan, Gao, Fuhai, Ding, Zitong, Yang, Shuiqing, Tian, Guiqin, Liu, Zongjian, Xi, Jianing
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Baicalein improves infarct volume and sensorimotor functions after MCAO.•Baicalein modulates microglial polarization to anti-inflammatory phenotype.•Baicalein regulates the neuroinflammatory response.•Baicalein affects polarization via inhibiting the TLR4/NF-κB and STAT1 activity.•Baicalein inhibits the toxicity of proinflammatory microglia on post-OGD neurons. Microglial polarization mediated neuroinflammation plays an important role in the pathological process of stroke. The aim of this study is to determine whether baicalein indirectly ameliorates neuronal injury through modulating microglial polarization after stroke and if so, then by what mechanism. The effects of baicalein on microglial polarization were revealed through the middle cerebral artery occlusion mouse model (MCAO, n = 6), the lipopolysaccharide (LPS) + interferon-γ (IFN-γ) and oxygen-glucose deprivation (OGD) induced neuroinflammatory microglia model (BV2, n = 3), respectively. Mice were treated with baicalein (100 mg/kg, i.g.) after reperfusion, and followed by daily administrations for 3 days. Results showed that the infarct volumes at 3 d in vehicle and baicalein-treated MCAO mice were 91.18 ± 4.02% and 55.36 ± 4.10%. Baicalein improved sensorimotor functions (p 
ISSN:0006-8993
1872-6240
DOI:10.1016/j.brainres.2021.147626